Evidence map›Paper›PMID 26509276›Full record

ArticlePloS one2015

Bioinformatics Knowledge Map for Analysis of Beta-Catenin Function in Cancer.

İrem Çelen, Karen E Ross, Cecilia N Arighi, Cathy H Wu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. The autism-associated loss of δ-catenin functions disrupts social behavior.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Tutorial on Protein Ontology Resources.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

İrem ÇelenCenter for Bioinformatics and Computational Biology, University of Delaware, Newark, Delaware, United States of America.
Karen E RossCenter for Bioinformatics and Computational Biology, University of Delaware, Newark, Delaware, United States of America; Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, D. C., United States of America.
Cecilia N ArighiCenter for Bioinformatics and Computational Biology, University of Delaware, Newark, Delaware, United States of America.
Cathy H WuCenter for Bioinformatics and Computational Biology, University of Delaware, Newark, Delaware, United States of America.
University of Delaware · US

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI Anjana Narayan Bhat · 2012 to 2026
$67.2M
PRO: A Protein Ontology in Open Biomedical OntologiesR01GM080646 · NIGMS · UNIVERSITY OF DELAWARE · PI WU, CATHY H. · 2007 to 2018
$8.9M
Biocreative Conference GrantR13GM109648 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI ARIGHI, CECILIA NOEMI, COHEN, KEVIN B. · 2014 to 2016
$36k
NIGMS NIH HHS P20 GM103446NIGMS NIH HHS P20GM103446NIGMS NIH HHS R01 GM080646NIGMS NIH HHS R01GM080646NIGMS NIH HHS R13 GM109648
6 · The paper itself

Abstract

Given the wealth of bioinformatics resources and the growing complexity of biological information, it is valuable to integrate data from disparate sources to gain insight into the role of genes/proteins in health and disease. We have developed a bioinformatics framework that combines literature mining with information from biomedical ontologies and curated databases to create knowledge "maps" of genes/proteins of interest. We applied this approach to the study of beta-catenin, a cell adhesion molecule and transcriptional regulator implicated in cancer. The knowledge map includes post-translational modifications (PTMs), protein-protein interactions, disease-associated mutations, and transcription factors co-activated by beta-catenin and their targets and captures the major processes in which beta-catenin is known to participate. Using the map, we generated testable hypotheses about beta-catenin biology in normal and cancer cells. By focusing on proteins participating in multiple relation types, we identified proteins that may participate in feedback loops regulating beta-catenin transcriptional activity. By combining multiple network relations with PTM proteoform-specific functional information, we proposed a mechanism to explain the observation that the cyclin dependent kinase CDK5 positively regulates beta-catenin co-activator activity. Finally, by overlaying cancer-associated mutation data with sequence features, we observed mutation patterns in several beta-catenin PTM sites and PTM enzyme binding sites that varied by tissue type, suggesting multiple mechanisms by which beta-catenin mutations can contribute to cancer. The approach described, which captures rich information for molecular species from genes and proteins to PTM proteoforms, is extensible to other proteins and their involvement in disease.

Indexed as

Computational BiologyModels, Biologicalbeta CateninCluster AnalysisGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMutationNeoplasmsProtein BindingProtein Interaction MappingProtein Interaction MapsSignal TransductionTranscriptional Activationbeta Catenin

Identifiers

PMID26509276
PMCPMC4624812
OpenAlexW2208787481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.